2002PubMedRequires access

[Vitrectomy for severe Coats' disease].

Rui Jiang, Qinyuan Chen, Wenji Wang

Open publisher page 0 citations

Abstract

OBJECTIVE: To investigate the outcome of vitreoretinal surgery for severe Coats' disease. METHODS: From December 1995 to December 1999, trans pars plana vitrectomy was performed in 11 patients (11 eyes) diagnosed as Coats' disease. Ten of them were complicated with total retinal detachment, and the other one had tractional retinal detachment caused by epiretinal proliferation. All these patients were followed up from 3 months to 4.5 years. RESULTS: All of the patients obtained useful vision except 1 patient whose operation was given up because of severe shortening of the retina. Three patients had the visual acuity higher than 0.02, and the best vision was 0.2. Obliteration of all abnormal vessels and resorption of all exudate was found postoperatively from 1 month to 3 months. Although the retina had been reattached in 10 patients during the operation, re-detachment was found in 4 patients postoperatively. After therapy all re-detached retina was reattached. The success rate was 90.9%. CONCLUSIONS: Vitrectomy with endolaser or scleral cryotherapy is an ideal therapy for severe Coats' disease, although the visual prognosis is still limited. It can preserve the limited vision, and prevent the severe complications such as rubeosis iridis, glaucoma, and phthisis bulbi.

About this research paper

What this paper is about

OBJECTIVE: To investigate the outcome of vitreoretinal surgery for severe Coats' disease. METHODS: From December 1995 to December 1999, trans pars plana vitrectomy was performed in 11 patients (11 eyes) diagnosed as Coats' disease. Ten of them were complicated with total retinal detachment, and the other one had tractional retinal detachment caused by epiretinal proliferation. All these patients were followed up from 3 months to 4.5 years. RESULTS: All of the patients obtained useful vision except 1 patient whose operation was given up because of severe shortening of the retina. Three patients had the visual acuity higher than 0.02, and the best vision was 0.2. Obliteration of all abnormal vessels and resorption of all exudate was found postoperatively from 1 month to 3 months. Although the retina had been reattached in 10 patients during the operation, re-detachment was found in 4 patients postoperatively. After therapy all re-detached retina was reattached. The success rate was 90.9%. CONCLUSIONS: Vitrectomy with endolaser or scleral cryotherapy is an ideal therapy for severe Coats' disease, although the visual prognosis is still limited. It can preserve the limited vision, and prevent the severe complications such as rubeosis iridis, glaucoma, and phthisis bulbi.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To investigate the outcome of vitreoretinal surgery for severe Coats' disease. METHODS: From December 1995 to December 1999, trans pars plana vitrectomy was performed in 11 patients (11 eyes) diagnosed as Coats' disease. Ten of them were complicated with total retinal detachment, and the other one had tractional retinal detachment caused by epiretinal proliferation. All these patients were followed up from 3 months to 4.5 years. RESULTS: All of the patients obtained useful vision except 1 patient whose operation was given up because of severe shortening of the retina. Three patients had the visual acuity higher than 0.02, and the best vision was 0.2. Obliteration of all abnormal vessels and resorption of all exudate was found postoperatively from 1 month to 3 months. Although the retina had been reattached in 10 patients during the operation, re-detachment was found in 4 patients postoperatively. After therapy all re-detached retina was reattached. The success rate was 90.9%. CONCLUSIONS: Vitrectomy with endolaser or scleral cryotherapy is an ideal therapy for severe Coats' disease, although the visual prognosis is still limited. It can preserve the limited vision, and prevent the severe complications such as rubeosis iridis, glaucoma, and phthisis bulbi.

Key concepts: Coats' disease, Medicine, Vitrectomy, Retinal detachment, Pars plana, Phthisis bulbi, Cryotherapy, Ophthalmology

Related papers

Back to paper searchBrowse research topicsOriginal source
[Vitrectomy for severe Coats' disease]. — Research Paper | ScholarLens